Stern RS. The prevalence of acne on the basis of physical examination. J Am Acad Dermatol. 1992;26(6):931–5.

PubMed  Google Scholar 

Prasad PV, Kaviarasan PK, Joseph JM, Madhuri S, Viswanathan P. Familial acne inversa with acne conglobata in three generations. Indian J Dermatol Venereol Leprol. 2008;74(3):283–5.

PubMed  Google Scholar 

Wollenberg A, Wolff H, Jansen T, Schmid MH, Röcken M, Plewig G. Acne conglobata and Klinefelter’s syndrome. Br J Dermatol. 1997;136(3):421–3.

PubMed  Google Scholar 

Miskinyte S, Nassif A, Merabtene F, et al. Nicastrin mutations in French families with hidradenitis suppurativa. J Investig Dermatol. 2012;132(6):1728–30.

PubMed  Google Scholar 

Li CR, Jiang MJ, Shen DB, et al. Two novel mutations of the nicastrin gene in Chinese patients with acne inversa. Br J Dermatol. 2011;165(2):415–8.

PubMed  Google Scholar 

Ratnamala U, Jhala D, Jain NK, et al. Expanding the spectrum of γ-secretase gene mutation-associated phenotypes: two novel mutations segregating with familial hidradenitis suppurativa (acne inversa) and acne conglobata. Exp Dermatol. 2016;25(4):314–6.

PubMed  Google Scholar 

Jastrząb B, Szepietowski JC, Matusiak Ł. Hidradenitis suppurativa and follicular occlusion syndrome: where is the pathogenetic link? Clin Dermatol. 2023;41(5):576–83.

PubMed  Google Scholar 

Jugeau S, Tenaud I, Knol AC, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153(6):1105–13.

PubMed  Google Scholar 

Grech I, Giatrakou S, Damoraki G, et al. Single nucleotide polymorphisms of toll-like receptor-4 protect against acne conglobata. J Eur Acad Dermatol Venereol. 2012;26(12):1538–43.

PubMed  Google Scholar 

Jiang J, Tang J, Tan Y, Wu R, Luo S. Acne conglobata caused by Cutibacterium avidum. Adv Dermatol Allergol. 2022;39(6):1183–5.

Google Scholar 

Corvec S. Clinical and biological features of Cutibacterium (formerly Propionibacterium) avidum, an underrecognized microorganism. Clin Microbiol Rev. 2018;31(3):e00064-e117.

PubMed  PubMed Central  Google Scholar 

Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, Ruzafa-Costas B, Agüera-Santos J, Navarro-López V. Acne, microbiome, and probiotics: the gut-skin axis. Microorganisms. 2022;10(7):1303.

PubMed  PubMed Central  Google Scholar 

Deng Y, Wang H, Zhou J, Mou Y, Wang G, Xiong X. Patients with acne vulgaris have a distinct gut microbiota in comparison with healthy controls. Acta Derm Venereol. 2018;98(8):783–90.

PubMed  Google Scholar 

Yan HM, Zhao HJ, Guo DY, Zhu PQ, Zhang CL, Jiang W. Gut microbiota alterations in moderate to severe acne vulgaris patients. J Dermatol. 2018;45(10):1166–71.

PubMed  Google Scholar 

Richards AL, Muehlbauer AL, Alazizi A, et al. Gut microbiota has a widespread and modifiable effect on host gene regulation. mSystems. 2019;4(5):e00323-e418.

PubMed  PubMed Central  Google Scholar 

Nolan ZT, Banerjee K, Cong Z, et al. Treatment response to isotretinoin correlates with specific shifts in Cutibacterium acnes strain composition within the follicular microbiome. Exp Dermatol. 2023;32(7):955–64.

PubMed  PubMed Central  Google Scholar 

Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges. 2007;5(2):110–7.

PubMed  Google Scholar 

El-Hamd MA, El Taieb MA, Ibrahim HM, Aly SS. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin. J Cosmet Dermatol. 2019;18(1):16–20.

PubMed  Google Scholar 

Garnier G. Action rapide et remarquable de la vitamine D2 dans un cas d’acné conglobata [Fast and remarkable action of vitamin D2 in a case of acne conglobata]. Ann Dermatol Syphiligr (Paris). 1946;6(9):487.

PubMed  Google Scholar 

Greywal T, Zaenglein AL, Baldwin HE, et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol. 2017;77(1):109–17.

PubMed  Google Scholar 

Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)–a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66(3):409–15.

PubMed  Google Scholar 

Fremlin GA, Wernham AGH, Patel A, Orpin S. Acne conglobata and necrotizing scleritis: a previously unreported association. Clin Exp Dermatol. 2019;44(7):804–6.

PubMed  Google Scholar 

McCoy WH 4th, Otchere E, Rosa BA, et al. Skin ecology during sebaceous drought—how skin microbes respond to isotretinoin. J Investig Dermatol. 2019;139:732–5.

PubMed  Google Scholar 

Leyden JJ, McGinley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Investig Dermatol. 1986;86(4):390–3.

PubMed  Google Scholar 

Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020;34(10):2229–40.

PubMed  Google Scholar 

Daoud M, Suppa M, Heudens S, et al. Treatment of acne with isotretinoin should be avoided in patients with hidradenitis suppurativa “conglobata phenotype.” Dermatology. 2023;239(5):738–45.

PubMed  Google Scholar 

Tan BB, Lear JT, Smith AG. Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin Exp Dermatol. 1997;22(1):26–7.

PubMed  Google Scholar 

Lages RB, Bona SH, Silva FV, Gomes AK, Campelo V. Acne fulminans successfully treated with prednisone and dapsone. An Bras Dermatol. 2012;87(4):612–4.

PubMed  Google Scholar 

Wakabayashi M, Fujimoto N, Uenishi T, Danno K, Tanaka T. A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory bowel disease. Dermatology. 2011;222(3):231–5.

PubMed  Google Scholar 

Liu P, Liu X, Zhang L, et al. ALA-PDT augments intense inflammation in the treatment of acne vulgaris by COX2/TREM1 mediated M1 macrophage polarization. Biochem Pharmacol. 2023;208:115403.

PubMed  Google Scholar 

Yang GL, Zhao M, Wang JM, et al. Short-term clinical effects of photodynamic therapy with topical 5-aminolevulinic acid for facial acne conglobata: an open, prospective, parallel-arm trial. Photodermatol Photoimmunol Photomed. 2013;29(5):233–8.

PubMed  Google Scholar 

Wu QY, Zhang Q, Bu WB, Fang F. A case of 5-aminolevulinic acid photodynamic therapy(ALA-PDT)combined with surgery for the treatment of acne conglobata. Photodiagnosis Photodyn Ther. 2022;39:102986.

PubMed  Google Scholar 

Ping Y, Jian Bo Z, Xing Yun Z, Ali K, Jun C, Xu Lou I, Wu LM. Case report: acne vulgaris treatment with 5-aminolaevulinic acid photodynamic therapy and adalimumab: a novel approach. Front Med (Lausanne). 2023;12(10):1187186.

Google Scholar 

Hasegawa T, Matsukura T, Suga Y, et al. Case of acne conglobata successfully treated by CO(2) laser combined with topical tretinoin therapy. J Dermatol. 2007;34(8):583–5.

PubMed  Google Scholar 

Sand FL, Thomsen SF. Adalimumab for the treatment of refractory acne conglobata. JAMA Dermatol. 2013;149(11):1306–7.

PubMed  Google Scholar 

Sand FL, Thomsen SF. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther. 2015;28(3):158–65.

PubMed  Google Scholar 

Yiu ZZ, Madan V, Griffiths CE. Acne conglobata and adalimumab: use of tumour necrosis factor-α antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol. 2015;40(4):383–6.

PubMed  Google Scholar 

Fernández-Crehuet P, Ruiz-Villaverde R. Acneiform eruption as a probable paradoxical reaction to adalimumab. Int J Dermatol. 2015;54(8):e306–8.

PubMed  Google Scholar 

Jiang W, Wang X, Li N, Chen J, Li C. Treating refractory acne conglobata with secukinumab: a case report. J Dermatol. 2024;51(2):e51–2.

PubMed  Google Scholar